境界性パーソナリティ障害の若者のための短い統合的神経認知療法 (SINTYA)
境界性パーソナリティ障害を持つ若者のための短い統合的神経認知療法: 衝動性管理の研究モデル
Borderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocognitive alterations linked to early trauma. The study authors hypothesize the SINTYA therapy program (one group session and one individual session weekly for 10 weeks) would reduce the level of impulsivity and clinical symptomatology (severity of the BPD; emotional regulation difficulties; dissociative symptoms; aggressiveness; ruminations; the number of self-destructive behaviors and suicidal acts; impulsive behaviors; level of suicide risk and hopelessness; the number of psychiatric hospitalizations and emergency visits for psychiatric reasons; and finally improving psychosocial functioning).
調査の概要
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Nîmes、フランス
- CHU de Nîmes
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Diagnosis of BPD according to DSM-5 criteria and BPQ-80 scale.
- High BPD severity level: ZAN-BPD (score ≥ 18/36).
- Understand, write and read French.
- Be able to understand the nature, purpose and methodology of the study and agree to cooperate during evaluations.
- Have signed the informed consent.
- For minor patients, have signed the parental consent by at least one holder of parental authority.
Exclusion Criteria:
- Refusal to participate.
- Existence of a neurological pathology or cerebral sequelae of organic origin which could affect neurocognitive performance.
- Intelligence quotient < 70.
- Lifetime diagnosis of schizoaffective disorder or schizophrenia (MINI-7).
- Previous or current participation in specific psychotherapy for BPD.
- Subject deprived of liberty (by judicial or administrative decision) and/or protected by law.
- Inclusion in another study including psychotherapy for the duration of the study.
- Inclusion in a drug RIPH1 study or in a REC study (European regulation of clinical trials) for the entire duration of the study.
- Subject in period of exclusion from another research protocol.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:コントロール
|
|
|
実験的:シンティアグループ
|
10-week psychotherapy program consisting of a weekly 1h30 hour group therapy session plus 1 hour individual therapy session |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Variation in explicit impulsivity between groups
時間枠:Baseline
|
UPPS-S (Impulsive Behavior Scale Short version score) |
Baseline
|
|
Variation in explicit impulsivity between groups
時間枠:Month 4
|
UPPS-S (Impulsive Behavior Scale Short version score) |
Month 4
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Variation in explicit impulsivity between groups
時間枠:Month 7
|
UPPS-S (Impulsive Behavior Scale Short version score) |
Month 7
|
|
Variation in impulsiveness between groups
時間枠:Baseline
|
Barratt Impulsiveness Scale (BIS-11) (score out of 120) |
Baseline
|
|
Variation in impulsiveness between groups
時間枠:Month 4
|
Barratt Impulsiveness Scale (BIS-11) (score out of 120) |
Month 4
|
|
Variation in impulsiveness between groups
時間枠:Month 7
|
Barratt Impulsiveness Scale (BIS-11) (score out of 120) |
Month 7
|
|
BPD severity level between groups
時間枠:Baseline
|
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36) |
Baseline
|
|
BPD severity level between groups
時間枠:Month 4
|
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36) |
Month 4
|
|
BPD severity level between groups
時間枠:Month 7
|
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36) |
Month 7
|
|
Emotional regulation capacities between groups
時間枠:Baseline
|
Difficulties in Emotion Regulation Scale (DERS-18) |
Baseline
|
|
Emotional regulation capacities between groups
時間枠:Month 4
|
Difficulties in Emotion Regulation Scale (DERS-18) |
Month 4
|
|
Emotional regulation capacities between groups
時間枠:Month 7
|
Difficulties in Emotion Regulation Scale (DERS-18) |
Month 7
|
|
Dissociative symptoms between groups
時間枠:Baseline
|
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder |
Baseline
|
|
Dissociative symptoms between groups
時間枠:Month 4
|
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder |
Month 4
|
|
Dissociative symptoms between groups
時間枠:Month 7
|
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder |
Month 7
|
|
Aggression between groups
時間枠:Baseline
|
Aggression Questionnaire (AQ-12) |
Baseline
|
|
Aggression between groups
時間枠:Month 4
|
Aggression Questionnaire (AQ-12) |
Month 4
|
|
Aggression between groups
時間枠:Month 7
|
Aggression Questionnaire (AQ-12) |
Month 7
|
|
Ruminations between groups
時間枠:Baseline
|
Rumination Reflection Questionnaire (RRQ) |
Baseline
|
|
Ruminations between groups
時間枠:Month 4
|
Rumination Reflection Questionnaire (RRQ) |
Month 4
|
|
Ruminations between groups
時間枠:Month 7
|
Rumination Reflection Questionnaire (RRQ) |
Month 7
|
|
Number of self-destructive behaviors between groups
時間枠:Baseline
|
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview |
Baseline
|
|
Number of self-destructive behaviors between groups
時間枠:Month 4
|
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview |
Month 4
|
|
Number of self-destructive behaviors between groups
時間枠:Month 7
|
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview |
Month 7
|
|
Number of impulsive behaviors between groups
時間枠:Baseline
|
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related) |
Baseline
|
|
Number of impulsive behaviors between groups
時間枠:Month 4
|
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related) |
Month 4
|
|
Number of impulsive behaviors between groups
時間枠:Month 7
|
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related) |
Month 7
|
|
Level of suicide risk between groups
時間枠:Baseline
|
Columbia-Suicide Severity Rating Scale (C-SSRS) |
Baseline
|
|
Level of suicide risk between groups
時間枠:Month 4
|
Columbia-Suicide Severity Rating Scale (C-SSRS) |
Month 4
|
|
Level of suicide risk between groups
時間枠:Month 7
|
Columbia-Suicide Severity Rating Scale (C-SSRS) |
Month 7
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
時間枠:12 Months prior to inclusion
|
Information taken from patient medical file |
12 Months prior to inclusion
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
時間枠:Baseline
|
Information taken from patient medical file |
Baseline
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
時間枠:Month 4
|
Information taken from patient medical file |
Month 4
|
|
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
時間枠:Month 7
|
Information taken from patient medical file |
Month 7
|
|
Psychosocial functioning between groups
時間枠:Baseline
|
Functional Assessment Staging Tool (FAST) |
Baseline
|
|
Psychosocial functioning between groups
時間枠:Month 4
|
Functional Assessment Staging Tool (FAST) |
Month 4
|
|
Psychosocial functioning between groups
時間枠:Month 7
|
Functional Assessment Staging Tool (FAST) |
Month 7
|
|
Implicit impulsivity between groups
時間枠:Baseline
|
Continuous Performance Test (CPT) |
Baseline
|
|
Implicit impulsivity between groups
時間枠:Month 4
|
Continuous Performance Test (CPT) |
Month 4
|
|
Implicit impulsivity between groups
時間枠:Month 7
|
Continuous Performance Test (CPT) |
Month 7
|
|
Neurocognitive evaluation of implicit impulsivity between groups
時間枠:Baseline
|
Emotional Stroop (SE) customized to the study |
Baseline
|
|
Neurocognitive evaluation of implicit impulsivity between groups
時間枠:Month 4
|
Emotional Stroop (SE) customized to the study |
Month 4
|
|
Neurocognitive evaluation of implicit impulsivity between groups
時間枠:Month 7
|
Emotional Stroop (SE) customized to the study |
Month 7
|
|
Risk taking between groups
時間枠:Baseline
|
Balloon Analogue Risk Task (BART) |
Baseline
|
|
Risk taking between groups
時間枠:Month 4
|
Balloon Analogue Risk Task (BART) |
Month 4
|
|
Risk taking between groups
時間枠:Month 7
|
Balloon Analogue Risk Task (BART) |
Month 7
|
|
Decision making under risk conditions between groups
時間枠:Baseline
|
Game Dice Task (GDT) |
Baseline
|
|
Decision making under risk conditions between groups
時間枠:Month 4
|
Game Dice Task (GDT) |
Month 4
|
|
Decision making under risk conditions between groups
時間枠:Month 7
|
Game Dice Task (GDT) |
Month 7
|
協力者と研究者
捜査官
- 主任研究者:Clémentine Estric、CHU de Nimes
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
All IPD that underlie results in a publication
IPD 共有時間枠
Upon publication
IPD 共有アクセス基準
The IPD will be made available to other researchers upon reasonable request to the corresponding author
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。